Windlas Biotech informs about outcome of board meeting

13 Aug 2024 Evaluate
Windlas Biotech has informed that Board of Directors at its Meeting held on Tuesday, August 13, 2024, approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2024. In this regard it has enclosed the following: i. Un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2024. ii. Limited Review Report of the Auditors on Standalone and Consolidated Financial Results for the Quarter ended June 30, 2024. The meeting of the Board of Directors commenced at 12.45 pm and concluded at 2.00 pm.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

1084.90 18.00 (1.69%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...